Mattelaer J - Search Results

1

Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892.

Schröder FH, Whelan P, de Reijke TM, Kurth KH, Pavone-Macaluso M, Mattelaer J, van Velthoven RF, Debois M, Collette L; Members of the EORTC Genito-Urinary Group. Schröder FH, et al. Among authors: mattelaer j. Eur Urol. 2004 Apr;45(4):457-64. doi: 10.1016/j.eururo.2003.11.016. Eur Urol. 2004. PMID: 15041109 Clinical Trial.

2

Tolerability and safety of flutamide in monotherapy, with orchiectomy or with LHRH-a in advanced prostate cancer patients. A Belgian multicenter study of 905 patients.

Oosterlinck W, Casselman J, Mattelaer J, Van Velthoven R, Kurjatkin O, Schulman C. Oosterlinck W, et al. Among authors: mattelaer j. Eur Urol. 1996;30(4):458-63. doi: 10.1159/000474215. Eur Urol. 1996. PMID: 8977067 Clinical Trial.

3

PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients.

Oosterlinck W, Mattelaer J, Casselman J, Van Velthoven R, Derde MP, Kaufman L. Oosterlinck W, et al. Among authors: mattelaer j. Acta Urol Belg. 1997 Oct;65(3):63-71. Acta Urol Belg. 1997. PMID: 9421938 Clinical Trial.

4

Identification by quantitative chromatin pattern analysis of patients at risk for recurrence of superficial transitional bladder carcinoma.

van Velthoven R, Petein M, Oosterlinck W, De Wilde T, Mattelaer J, Hardeman M, Kiss R, Decaestecker C. van Velthoven R, et al. Among authors: mattelaer j. J Urol. 2000 Dec;164(6):2134-7. doi: 10.1097/00005392-200012000-00078. J Urol. 2000. PMID: 11061942

5

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez Torecilla J, Pfeffer JR, Lino Cutajar C, Zurlo A, Pierart M. Bolla M, et al. Among authors: mattelaer j. Lancet. 2002 Jul 13;360(9327):103-6. doi: 10.1016/s0140-6736(02)09408-4. Lancet. 2002. PMID: 12126818 Clinical Trial.

6

Prognostic factors in advanced prostatic carcinoma treated with total androgen blockade. Flutamide with orchiectomy or with LHRH analogues. A Belgian multicentric study of 546 patients.

Oosterlinck W, Mattelaer J, Derde MP, Kaufman L. Oosterlinck W, et al. Among authors: mattelaer j. Acta Urol Belg. 1995 Sep;63(3):1-9. Acta Urol Belg. 1995. PMID: 7484516 Clinical Trial.

7

Massive bilateral renal and perirenal hemorrhage due to polyarteritis nodosa: a life-threatening urologic condition.

Maes K, Billiet I, Haerens M, Mattelaer J. Maes K, et al. Among authors: mattelaer j. Eur Urol. 2000 Sep;38(3):349-51. doi: 10.1159/000020305. Eur Urol. 2000. PMID: 10940712 No abstract available.

8

Inverted papilloma of bladder: clinical significance.

Mattelaer J, Leonard A, Goddeeris P, D'Hoedt M, Van Kerrebroeck P. Mattelaer J, et al. Urology. 1988 Sep;32(3):192-7. doi: 10.1016/0090-4295(88)90383-4. Urology. 1988. PMID: 3413911

9

Use of transrectal longitudinal sonography in the placement of a prostatic coil.

Billiet I, Mattelaer J, Van Brien P. Billiet I, et al. Among authors: mattelaer j. Eur Urol. 1990;17(1):76-8. doi: 10.1159/000464006. Eur Urol. 1990. PMID: 2180722

10

The circumcision of Jesus Christ.

Mattelaer JJ, Schipper RA, Das S. Mattelaer JJ, et al. J Urol. 2007 Jul;178(1):31-4. doi: 10.1016/j.juro.2007.03.016. Epub 2007 May 11. J Urol. 2007. PMID: 17574055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page